Danaher Corporation $DHR is Zeno Equity Partners LLP’s Largest Position

Zeno Equity Partners LLP lifted its stake in Danaher Corporation (NYSE:DHR) by 2.6% in the 3rd quarter, Holdings Channel reports. The firm owned 265,795 shares of the conglomerate’s stock after purchasing an additional 6,856 shares during the quarter. Danaher accounts for approximately 24.5% of Zeno Equity Partners LLP’s portfolio, making the stock its biggest position. Zeno Equity Partners LLP’s holdings in Danaher were worth $52,756,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in DHR. WFA of San Diego LLC purchased a new stake in shares of Danaher during the 2nd quarter worth approximately $26,000. Howard Hughes Medical Institute acquired a new position in Danaher during the second quarter worth $27,000. ANTIPODES PARTNERS Ltd purchased a new stake in Danaher during the third quarter worth $27,000. TruNorth Capital Management LLC purchased a new stake in Danaher during the third quarter worth $28,000. Finally, Tripletail Wealth Management LLC acquired a new stake in Danaher in the third quarter valued at $31,000. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Danaher

In related news, EVP Gregory M. Milosevich sold 1,320 shares of the company’s stock in a transaction on Thursday, February 19th. The stock was sold at an average price of $208.01, for a total value of $274,573.20. Following the completion of the transaction, the executive vice president directly owned 5,099 shares in the company, valued at approximately $1,060,642.99. This represents a 20.56% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 11.10% of the stock is currently owned by corporate insiders.

Danaher Price Performance

Danaher stock opened at $209.56 on Friday. The stock has a market capitalization of $148.02 billion, a P/E ratio of 41.58, a P/E/G ratio of 2.83 and a beta of 0.91. Danaher Corporation has a 12-month low of $171.00 and a 12-month high of $242.80. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.87 and a quick ratio of 1.51. The firm’s 50-day moving average is $226.85 and its two-hundred day moving average is $215.89.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Tuesday, January 27th. The conglomerate reported $2.23 earnings per share for the quarter, beating analysts’ consensus estimates of $2.14 by $0.09. Danaher had a net margin of 14.71% and a return on equity of 10.81%. The business had revenue of $6.84 billion during the quarter, compared to analyst estimates of $6.79 billion. During the same quarter in the previous year, the business posted $2.14 earnings per share. The company’s revenue was up 4.6% on a year-over-year basis. Equities analysts predict that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, January 30th. Stockholders of record on Friday, December 26th were issued a dividend of $0.32 per share. The ex-dividend date was Friday, December 26th. This represents a $1.28 annualized dividend and a dividend yield of 0.6%. Danaher’s dividend payout ratio (DPR) is 25.40%.

Wall Street Analyst Weigh In

DHR has been the subject of several research reports. JPMorgan Chase & Co. lifted their price target on Danaher from $270.00 to $275.00 and gave the stock an “overweight” rating in a research note on Thursday, January 29th. Weiss Ratings restated a “hold (c)” rating on shares of Danaher in a report on Monday, December 29th. HSBC lifted their target price on shares of Danaher from $255.00 to $270.00 and gave the stock a “buy” rating in a research report on Monday, December 1st. Wall Street Zen upgraded shares of Danaher from a “hold” rating to a “buy” rating in a research report on Saturday, November 22nd. Finally, Robert W. Baird set a $251.00 price objective on shares of Danaher in a research note on Thursday, January 29th. Twenty investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat, Danaher has an average rating of “Moderate Buy” and an average target price of $253.86.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.